CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer

Frederik Marmé, Wiebke Werft, Anne Walter et al. · Breast Cancer Research and Treatment · 2011

Cited by 23 works. doi:10.1007/s10549-011-1759-9

Authors

References